| Age, sex, and race appear to have no clinically significant impact on the pharmacokinetics of azilsartan. |
| No adjustments in azilsartan medoxomil dosage are required on the basis of age, sex, or race. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.